Drug Information

General Information
Drug ID
DR00577
Drug Name
Cefazolin
Synonyms
(6R, 7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R-trans)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)-amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylic acid; 7-(1-(1H-)-Tetrazolylacetamido)-3-(2-(5-methyl-1,3,4-thiadiazolyl)thiomethyl)delta3-cephem-4-carboxylic acid; Ancef (TN); CEZ; Cefacidal (TN); Cefamezin; Cefamezin (TN); Cefamezine; Cefazolin (USP); Cefazolin [USAN:INN]; Cefazolin(usp); Cefazolina; Cefazolina [INN-Spanish]; Cefazoline; Cefazoline [INN-French]; Cefazolinum; Cefazolinum [INN-Latin]; Cefrina (TN); Cephamezine; Cephazolidin; Cephazolin; Cephazolin Sodium; Cephazoline; Elzogram; Elzogram (TN); Faxilen (TN); Gramaxin (TN); Kefazol (TN); Kefol (TN); Kefzol (TN); Kefzolan (TN); Kezolin (TN); Novaporin (TN); Zolicef (TN)
Drug Type
Small molecular drug
Indication Methicillin-susceptible staphylococcus aureus [ICD11: 1B74.0] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C14H14N8O4S3
Canonical SMILES
CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O
InChI
InChI=1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1
InChIKey
MLYYVTUWGNIJIB-BXKDBHETSA-N
CAS Number
CAS 25953-19-9
Pharmaceutical Properties Molecular Weight 454.5 Topological Polar Surface Area 235
Heavy Atom Count 29 Rotatable Bond Count 7
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 12
XLogP
-0.4
PubChem CID
33255
PubChem SID
103510684 , 104133789 , 104231690 , 104315593 , 11335189 , 11360428 , 11362960 , 11365522 , 11368084 , 11371259 , 11373873 , 11376246 , 11461400 , 11466764 , 11467884 , 11484775 , 11486367 , 11488956 , 11490146 , 11492082 , 11493920 , 117600526 , 124766146 , 14833488 , 15008581 , 29215418 , 34675123 , 46506123 , 47193754 , 47290958 , 47440062 , 47440063 , 47440064 , 47810578 , 48110278 , 48259043 , 48334299 , 48415713 , 50051012 , 56314760 , 57311487 , 602960 , 75509242 , 7849358 , 7978873 , 81093146 , 8173059 , 85663279 , 9097 , 92714647
ChEBI ID
CHEBI:474053
TTD Drug ID
D09KDN
DT(s) Transporting This Drug MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [2]
OAT1 Transporter Info Organic anion transporter 1 Substrate [3]
OAT3 Transporter Info Organic anion transporter 3 Substrate [3]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [4]
PEPT1 Transporter Info Peptide transporter 1 Substrate [5]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MRP4 Transporter Info Km = 81 microM Human embryonic kidney cells (HEK293)-MRP4 [2]
References
1 Cefazolin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21.
3 Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res. 2004 Jan;21(1):61-7.
4 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.
5 Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. J Med Chem. 2005 Jun 30;48(13):4410-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.